Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Olaya Hernández-Frías"'
Publikováno v:
Nefrología, Vol 35, Iss 6, Pp 517-522 (2015)
Pediatric chronic kidney disease (CKD) has peculiar features. In particular, growth impairment is a major clinical manifestation of CKD that debuts in pediatric age because it presents in a large proportion of infants and children with CKD and has a
Externí odkaz:
https://doaj.org/article/0a6cdfbf203a4a9e96b1bc2e29220dd7
Autor:
Olaya Hernández-Frías, Montserrat Antón-Gamero, Susana Ferrando-Monleón, Inés Vergara, Susana González-Sanchez, Gema Ariceta, Fernando Santos, Ángeles Fernández-Maseda, Helena Gil-Peña, Sara Chocron, Leire Madariaga, Reyner Loza, Francisco de la Cerda Ojeda, José M Pérez-Roldán, Marta Fernández-Fernández, M Isabel Luis-Yanes
Publikováno v:
Pediatric Nephrology. 34:1077-1086
To find out if cardiovascular alterations are present in pediatric patients with X-linked hypophosphatemia (XLH). Multicentre prospective clinical study on pediatric patients included in the RenalTube database ( www.renaltube.com ) with genetically c
Autor:
Olaya Hernández-Frías, Isabel Rubio-Aliaga, Rocío Fuente, Gonzalo Anes-González, Enrique Rodríguez-Rubio, Carsten A. Wagner, Debora Claramunt-Taberner, Laura Alonso-Durán, Francisco Hermida-Prado, Fernando Santos, Helena Gil-Peña, Ángela Fernández-Iglesias
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 33(7)
X-linked hypophosphatemia (XLH) leads to growth retardation and bone deformities, which are not fully avoided by conventional treatment with phosphate and vitamin D analogs. Pediatric patients have been treated with growth hormone (GH), and recent fi
Autor:
Fernando Santos, Debora Claramunt-Taberner, Rocío Fuente, Olaya Hernández-Frías, Isabel Rubio-Aliaga, José Manuel López, Gonzalo Anes-González, Francisco Hermida-Prado, Helena Gil-Peña, Ángela Fernández-Iglesias
Publikováno v:
Bone. 116
Mechanisms underlying growth impairment and bone deformities in X-linked hypophosphatemia are not fully understood. We here describe marked alterations in the structure, dynamics and maturation of growth plate in growth-retarded young Hyp mice, in co
Autor:
Flor A. Ordoñez, Fernando Santos, Olaya Hernández-Frías, Enrique García-López, Rocío Fuente, Helena Gil-Peña, Débora Claramunt, Vanessa Loredo, Julián Rodríguez-Suárez
Publikováno v:
American Journal of Physiology-Renal Physiology. 309:F57-F62
Growth retardation is a major manifestation of chronic kidney disease (CKD) in pediatric patients. The involvement of the various pathogenic factors is difficult to evaluate in clinical studies. Here, we present an experimental model of adenine-induc
Publikováno v:
Scopus
Nefrología, Vol 35, Iss 6, Pp 517-522 (2015)
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Nefrología (English Edition), Vol 35, Iss 6, Pp 517-522 (2015)
Nefrología (Madrid) v.35 n.6 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
Nefrología, Vol 35, Iss 6, Pp 517-522 (2015)
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Nefrología (English Edition), Vol 35, Iss 6, Pp 517-522 (2015)
Nefrología (Madrid) v.35 n.6 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
Pediatric chronic kidney disease (CKD) has peculiar features. In particular, growth impairment is a major clinical manifestation of CKD that debuts in pediatric age because it presents in a large proportion of infants and children with CKD and has a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f03adf61c635658767762765cde92f4
http://hdl.handle.net/10651/36871
http://hdl.handle.net/10651/36871
Autor:
Rocío Fuente, Flor A. Ordoñez, Fernando Santos, Enrique García-López, Julián Rodríguez-Suárez, Olaya Hernández Frías, Helena Gil-Peña, Débora Claramunt
Publikováno v:
Pediatric Research. 82:888-888
BackgroundIn a model of growth retardation secondary to chronic kidney disease (CKD) induced by adenine, this study explores the effects of growth hormone (GH) therapy on growth plate and mineral metabolism.MethodsWeaning female rats receiving a 0.5%